Comparative analysis of the dynamics of healthcare expenditures from country GDP and cash payments of families to medical and pharmaceutical support in Ukraine, CIS countries and ЕU

• Main Authors: Oleh Samborskyi, Mykola Slobodyanyuk, Нanna Panfilova
• Format: Article
• Language: English
• Published: PC Technology Center 2020-06-01
• Series: ScienceRise: Pharmaceutical Science
• Subjects: medical care; health care costs; cash payments made by families for medical and pharmaceutical support; healthcare; pharmaceutical care
• Online Access: http://journals.uran.ua/sr_pharm/article/view/206569

The aim: conducting a comparative analysis of the dynamics of changes in health expenditures (%) from GDP and cash payments of families for medical and pharmaceutical support from total health expenditures in Ukraine, CIS countries and the EU (members since 2004). Materials and methods. The data of the WHO Regional Office for Europe and such analysis methods as historical, analytical, comparative, systemic, logical, graphic, mathematical and statistical, etc. were used. Results. According to the results of the analysis, it was found that the ex­penditures (%) on health care from the GDP of countries and the cash payments (%) made by families on medical and pharmaceutical support from the total ex­penditures on health care in 1990-2014 steadily increasing. At the same time, it was proved that the growth rate (%) of these indicators in Ukraine, the CIS coun­tries and the EU differed both in numerical values and in years of research. The largest and smallest growth values of these indicators were characteristic of Ukraine. In addition, it was internal indicators that were zigzag in their changes, for example, expenditures (%) on health care of the country's GDP in 1995 in­creased to 7.0 % from 3.3 % (1994). It is proved that in Ukraine during 1990-2014 against the background of an increase in expenditures (%) on healthcare from the country's GDP by 2.14 times. Cash (%) payments to the population of total health spending increased 1.9 times. In the CIS countries, over the same period, the above expenses increased 1.7 times, and family cash payments 1.8 times, and in the EU 1.4 times and 1.04 times respectively. Thus, it can be argued that the population of European countries against the background of a systematic increase in health care costs (%) of the country's GDP invariably spends in the form of cash payments for medical and pharmaceutical support no more than 25.0 % of the total health care costs in national health systems. Conclusions. The presence of unstable dynamics of changes in these macro­economic indicators in Ukraine and the CIS countries compared with similar data that are presented for the EU countries is the result of a lack of a systematic vision of the reform processes of national health systems, as well as a lack of a consistent state policy to provide effective financial support to the population in the process of providing medical and pharmaceutical care